laurus labs EMA cross over DAILY CHART
Laurus Labs (LAURUS)’s Annual Report Analysis indicates a sharp improvement in
ROE, led by a strong head-start in Finished dosage forms (FDF), improving operating
profit, and a reduced interest rate, the brokerages have upgraded their target as well;
ROE, led by a strong head-start in Finished dosage forms (FDF), improving operating
profit, and a reduced interest rate, the brokerages have upgraded their target as well;
免責事項
これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。